{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Ryou IS"],"pubmed_abstract":["The reported beneficial effects of statins on cardiovascular outcome based on risk assessment are inconsistent. Therefore, we investigated statin therapy effectiveness for the primary prevention of cardiovascular disease (CVD), according to the Korean Risk Prediction Model (KRPM). Subjects aged 40-79 years with low density lipoprotein cholesterol (LDL-C) of < 190 mg/dL and without CVD history were categorized as statin users or non-users using the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database, Korea, 2002-2015. The 10-year atherosclerotic CVD (ASCVD) risk was calculated using the validated KRPM and categorized as low, borderline, intermediate, or high-risk groups; the incidence of major adverse cardiovascular events (MACEs) was compared over a mean follow-up "],"journal":["Frontiers in medicine"],"pagination":["1024780"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9669657"],"repository":["biostudies-literature"],"pubmed_title":["Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study."],"pmcid":["PMC9669657"],"pubmed_authors":["Kim S","Kim JY","Ryou IS","Kim HJ","Park HY","Oh S"],"additional_accession":[]},"is_claimable":false,"name":"Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study.","description":"The reported beneficial effects of statins on cardiovascular outcome based on risk assessment are inconsistent. Therefore, we investigated statin therapy effectiveness for the primary prevention of cardiovascular disease (CVD), according to the Korean Risk Prediction Model (KRPM). Subjects aged 40-79 years with low density lipoprotein cholesterol (LDL-C) of < 190 mg/dL and without CVD history were categorized as statin users or non-users using the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database, Korea, 2002-2015. The 10-year atherosclerotic CVD (ASCVD) risk was calculated using the validated KRPM and categorized as low, borderline, intermediate, or high-risk groups; the incidence of major adverse cardiovascular events (MACEs) was compared over a mean follow-up ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-19T06:38:48.019Z","creation":"2025-04-19T06:38:48.019Z"},"accession":"S-EPMC9669657","cross_references":{"pubmed":["36405617"],"doi":["10.3389/fmed.2022.1024780"]}}